Clinical Trial Update: Study of Developing an Optimal Gemcitabine Based Regimen to Treat Elderly Patients With Advanced Non-Small Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update studying a gemcitabine-based regimen to treat elderly patients with advanced non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Gemzar (gemcitabine)

Snippet

Sponsor: Ulsan University Hospital | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 2 | Status: UNKNOWN